Concepedia

Author

Josef S Smolen

Medical University of Vienna

Also Known As

A. Young, C. Walsh, Hazes, Johanna M. W., Herold, Manfred, J Gretler, J S SMOLEN, J S Smolen, J SMOLEN, J Smolen, J Smoleń

824

Publications

85.2K

Citations

118

H-Index

164

Concepts

All Affiliations

Medical University of ViennaKlinik HietzingUniversity of ViennaLeiden University Medical CenterUniversity of Leeds
JS

About

Josef S Smolen is an author at Medical University of Vienna specializing in medicine, rheumatology, and rheumatoid arthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

39

68

9.3K

2

Health Sciences

9

9

580

3

Natural Sciences

2

2

90

4

Engineering

1

1

12

5

Management

1

1

38

Josef S Smolen

×

310

Publications

68.7K

Citations

103

H-Index

YearCitations

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Daniel Aletaha, Tuhina Neogi, Alan J. Silman,

Arthritis & Rheumatism

2010

9.3K

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

D. Aletaha, Tuhina Neogi, Alan J. Silman,

Annals of the Rheumatic Diseases

2010

4.7K

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair,

New England Journal of Medicine

2000

3K

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Martin Aringer, Karen H. Costenbader, David Daikh,

Arthritis & Rheumatology

2019

2.3K

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno,

Annals of the Rheumatic Diseases

2019

1.9K

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann,

The Lancet

1994

1.7K

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden,

Arthritis & Rheumatism

1998

1.6K

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community

Claudio Vitali, Stefano Bombardieri, Haralampos Μ. Moutsopoulos,

Arthritis & Rheumatism

1993

1.4K

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Josef S Smolen, André Beaulieu, Andrea Rubbert‐Roth,

The Lancet

2008

1.4K

EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Weiya Zhang, Michael Doherty, Burkhard F. Leeb,

Annals of the Rheumatic Diseases

2006

1.3K

Page 1